IE40477L - Androstane derivatives. - Google Patents
Androstane derivatives.Info
- Publication number
- IE40477L IE40477L IE750083A IE8375A IE40477L IE 40477 L IE40477 L IE 40477L IE 750083 A IE750083 A IE 750083A IE 8375 A IE8375 A IE 8375A IE 40477 L IE40477 L IE 40477L
- Authority
- IE
- Ireland
- Prior art keywords
- isomer
- androst
- jan
- pure
- gonadinhibiting
- Prior art date
Links
- 150000001440 androstane derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- ISJVDMWNISUFRJ-HKQXQEGQSA-N (5s,8r,9s,10s,13s,14s)-10,13-dimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one Chemical compound C1C=CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 ISJVDMWNISUFRJ-HKQXQEGQSA-N 0.000 abstract 1
- ISJVDMWNISUFRJ-UHFFFAOYSA-N 5alpha-androstan-2-en-17-one Natural products C1C=CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 ISJVDMWNISUFRJ-UHFFFAOYSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 239000003810 Jones reagent Substances 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salt Chemical class 0.000 abstract 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001817 pituitary effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000011369 resultant mixture Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1492746 #<SP>2</SP>-Androstenes THERAMEX SA 17 Jan 1975 [17 Jan 1974] 02211/74 Heading C2U [Also in Division A5] The invention comprises 17α-ethynyl-5α- androst-2-en-17#-ol and its acetate free from their respective #<SP>3</SP>-isomers; and their preparation from the analogously pure corresponding 17-one by reaction with an alkali metal salt (simple or complex) of acetylene, followed when required by acetylation. 5α - Androst - 2 - en - 17 - one is freed from admixed #<SP>3</SP>-isomer thereof by treatment with Jones reagent and isolation of the pure #<SP>2</SP> compound from the resultant mixture, e.g. by crystallization or chromatography. (The #<SP>3</SP>- isomer is thought to be converted to a diacid or aldehyde while the #<SP>2</SP>-isomer remains unchanged). The inventive compounds are credited with pituitary gonadotrophin-stimulating, gonadinhibiting, antitumour, contraceptive, anti-parathyroid and anti-seborrhoeic activities, and may be made up with carriers into pharmaceutical compositions for oral, parenteral, topical and rectal administration.
[GB1492746A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2211/74A GB1492746A (en) | 1974-01-17 | 1974-01-17 | Androstane derivatives and compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE40477L true IE40477L (en) | 1975-07-17 |
| IE40477B1 IE40477B1 (en) | 1979-06-06 |
Family
ID=9735557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE83/75A IE40477B1 (en) | 1974-01-17 | 1975-01-17 | Androstane derivatives and compositions containing them |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS576439B2 (en) |
| AR (1) | AR203672A1 (en) |
| AU (1) | AU521392B2 (en) |
| BE (1) | BE823594A (en) |
| BR (1) | BR7500346A (en) |
| CA (1) | CA1065851A (en) |
| CH (1) | CH606091A5 (en) |
| DE (1) | DE2501091A1 (en) |
| DK (1) | DK135538B (en) |
| ES (1) | ES433677A1 (en) |
| FR (1) | FR2258185B1 (en) |
| GB (1) | GB1492746A (en) |
| IE (1) | IE40477B1 (en) |
| IT (1) | IT1044268B (en) |
| LU (1) | LU71662A1 (en) |
| NL (1) | NL183402C (en) |
| PH (1) | PH15366A (en) |
| SE (1) | SE7500479L (en) |
| ZA (1) | ZA75254B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0066001B1 (en) * | 1981-06-02 | 1986-05-14 | Laboratoire Théramex | Pharmaceutical compositions containing androstenes |
| JPS60173248A (en) * | 1984-02-16 | 1985-09-06 | 三晃金属工業株式会社 | Inlaid outer enclosure |
| US5116830A (en) * | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
| WO1986001208A1 (en) * | 1984-08-17 | 1986-02-27 | Sri International | Stereoisometrically pure 17-alpha-ethynyl-estra-2-en-17beta-ol and esters thereof |
| EP0200591B1 (en) * | 1985-04-29 | 1989-01-18 | Laboratoire Theramex | Process for the preparation of pure androst-2-ene derivatives |
| FR2598083B1 (en) * | 1986-05-05 | 1989-12-29 | Theramex Laboratoire | NOVEL PHARMACEUTICAL COMPOSITIONS WITH ANTIPROGESTERONIC ACTION AND PROCESS FOR OBTAINING SAME |
| RU2652702C2 (en) | 2016-10-19 | 2018-04-28 | Игорь Ву-Юнович Ван | Sub-atmospheric system of heat and cold supply |
-
1974
- 1974-01-17 GB GB2211/74A patent/GB1492746A/en not_active Expired
- 1974-12-18 CH CH1734774A patent/CH606091A5/xx not_active IP Right Cessation
- 1974-12-19 BE BE151716A patent/BE823594A/en unknown
- 1974-12-30 DK DK690574AA patent/DK135538B/en not_active IP Right Cessation
- 1974-12-31 FR FR7443397A patent/FR2258185B1/fr not_active Expired
-
1975
- 1975-01-09 ES ES433677A patent/ES433677A1/en not_active Expired
- 1975-01-13 DE DE19752501091 patent/DE2501091A1/en active Pending
- 1975-01-14 JP JP698075A patent/JPS576439B2/ja not_active Expired
- 1975-01-14 ZA ZA00750254A patent/ZA75254B/en unknown
- 1975-01-15 AU AU77335/75A patent/AU521392B2/en not_active Expired
- 1975-01-16 LU LU71662A patent/LU71662A1/xx unknown
- 1975-01-16 CA CA218,033A patent/CA1065851A/en not_active Expired
- 1975-01-16 PH PH16719A patent/PH15366A/en unknown
- 1975-01-16 IT IT19319/75A patent/IT1044268B/en active
- 1975-01-16 SE SE7500479A patent/SE7500479L/xx unknown
- 1975-01-17 NL NLAANVRAGE7500608,A patent/NL183402C/en not_active IP Right Cessation
- 1975-01-17 BR BR346/75A patent/BR7500346A/en unknown
- 1975-01-17 AR AR257331A patent/AR203672A1/en active
- 1975-01-17 IE IE83/75A patent/IE40477B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE823594A (en) | 1975-04-16 |
| NL183402C (en) | 1988-10-17 |
| LU71662A1 (en) | 1975-06-24 |
| NL7500608A (en) | 1975-07-21 |
| ES433677A1 (en) | 1976-11-16 |
| NL183402B (en) | 1988-05-16 |
| JPS576439B2 (en) | 1982-02-04 |
| CH606091A5 (en) | 1978-10-13 |
| ZA75254B (en) | 1976-01-28 |
| FR2258185A1 (en) | 1975-08-18 |
| GB1492746A (en) | 1977-11-23 |
| AR203672A1 (en) | 1975-09-30 |
| SE7500479L (en) | 1975-07-18 |
| BR7500346A (en) | 1975-11-04 |
| IT1044268B (en) | 1980-03-20 |
| IE40477B1 (en) | 1979-06-06 |
| DK135538B (en) | 1977-05-16 |
| AU521392B2 (en) | 1982-04-01 |
| CA1065851A (en) | 1979-11-06 |
| FR2258185B1 (en) | 1978-07-28 |
| AU7733575A (en) | 1976-07-15 |
| DK690574A (en) | 1975-09-29 |
| DK135538C (en) | 1977-10-24 |
| DE2501091A1 (en) | 1975-07-24 |
| JPS50106952A (en) | 1975-08-22 |
| PH15366A (en) | 1982-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1429922A (en) | Steroid acetals processes for their manufacture and preparations containing them | |
| GB1279186A (en) | 7-methyl,3,5-cyclo-androstanes and their preparation and conversion to other steroids | |
| GB1515284A (en) | Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series | |
| IE40477L (en) | Androstane derivatives. | |
| GB1373548A (en) | Anti-hypertensive 6-substituted 3-hydrazino-pyridazines and their preparation | |
| YU35148B (en) | Process for obtaining pregnane acid derivatives | |
| GB1424297A (en) | Process for vapour phase ammoxidation | |
| IE40163B1 (en) | Pharmaceutical compositions containing steroids | |
| IE36060L (en) | Acyl derivatives of digoxin. | |
| GB1397434A (en) | Evomonoside derivatives | |
| IE43708L (en) | D-homosteroid carboxylic acids | |
| US3352891A (en) | 19-norsteroidal-17-nitrates | |
| GB1348941A (en) | 6,6-difluoro-pregnenes-3,17-diones | |
| JPS58876B2 (en) | FR-1923 Bushitsuno Seizouhouhou | |
| GB1363150A (en) | 17alpha-propadienyl steroids | |
| GB1501592A (en) | Pharmaceutical compositions | |
| US4005078A (en) | Dithioketal derivatives of 13-polycarbonalkylgon-4-en-3-ones | |
| GB1386439A (en) | Substituted gonenes processes for their preparation and compositions incorporating them | |
| GB1481964A (en) | Process for the manufacture of 17beta-oxalylsteroids | |
| IE36944L (en) | 17ó-ethynyl-estriols. | |
| GB1430924A (en) | 1,3-diethers of 2-azaestratrienes | |
| GB1050249A (en) | ||
| GB1504294A (en) | 6 beta-fluoropregnane compounds | |
| GB887337A (en) | New benzo-bis-imidazoles and process for their manufacture | |
| GB1464109A (en) | Antibacterial acylaminoquinoxaline carboxamide 1,4-dioxides |